Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Ergebnis 17 von 10830

Details

Autor(en) / Beteiligte
Titel
Exocyclically metallated tetrapyridinoporphyrazine as a potential photosensitizer for photodynamic therapy
Ist Teil von
  • Photochemical & photobiological sciences, 2019, Vol.18 (11), p.2792-283
Ort / Verlag
Cham: Springer International Publishing
Erscheinungsjahr
2019
Link zum Volltext
Quelle
Springer journals
Beschreibungen/Notizen
  • We report the first exocyclically metallated tetrapyridinoporphyrazine, [tetrakis-( trans -Pt(NH 3 ) 2 Cl)-tetra(3,4-pyrido)porphyrazine-zinc( ii )](NO 3 ) 4 ( 4 ), synthesized in a multistep synthesis starting from 3,4-pyridinedicarbonitrile ( 1 ). The synthetic procedure involved a platination reaction of the intermediate tetra(3,4-pyrido)porphyrazine-zinc( ii ) ( 2 ), whereby the zinc( ii ) enhanced the solubility of the intermediate enabling the platination reaction. A similar approach to synthesize [tetrakis-( trans -Pt(NH 3 ) 2 Cl)-tetra(3,4-pyrido)porphyrazine](NO 3 ) 4 ( 5 ) failed due to the unsuitable solubility properties of the intermediate tetra(3,4-pyrido)porphyrazine ( 3 ). The final product 4 and the intermediates were characterized, the photochemical and photophysical properties were determined and the photocytotoxicities were investigated. We demonstrate that the platinated tetra-pyridinoporphyrazine 4 is a potential photosensitizer for photodynamic therapy (PDT). Synthesis and biological evaluations of a potential dual chemotherapeutic photosensitizer for photodynamic therapy based on the first exocyclically platinated tetrapyridinoporphyrazine.
Sprache
Englisch
Identifikatoren
ISSN: 1474-905X
eISSN: 1474-9092
DOI: 10.1039/c9pp00336c
Titel-ID: cdi_springer_journals_10_1039_c9pp00336c

Weiterführende Literatur

Empfehlungen zum selben Thema automatisch vorgeschlagen von bX